30-day average of 14 articles ยท scale โ100 to +100
Across 14 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Ecolab news is Bullish (+55)
on a scale from โ100 to +100.
That is about the same as the previous 30 days (+54).
๐ Q3 sales rose 13% YoY to $4.69B with organic growth accelerating to 7%.
๐ฐ Adjusted operating income jumped 14% driven by improved leverage and efficiency.
Bullish +65
Ecolab stock enters 2027 with stronger growth and margin momentum
AI-generated analysis
Key insights
๐ Ecolab reported third-quarter sales rising 13 percent year over year to $4.69 billion, with organic growth accelerating to 7 percent.
๐ฐ Reported operating income increased 7 percent, while adjusted operating income rose 14 percent due to improved leverage.
๐ Global High-Tech organic sales surged 63 percent, and Life Sciences organic sales grew 17 percent in the third quarter.
๐ป Ecolab Digital sales climbed 34 percent to $129 million, driven by demand for water efficiency and AI infrastructure solutions.
๐ฏ Management forecasts fourth-quarter reported sales growth of 12 to 14 percent with organic growth between 6 and 7 percent.
๐ Full-year 2026 adjusted diluted earnings per share are expected to reach $8.10 to $8.20, an increase of 8 to 9 percent.
๐ฎ The company targets an adjusted operating margin of 20 percent for 2027 as acquisition-related comparisons normalize.
๐ค Acquisitions Ovivo Electronics and CoolIT are expected to add about two percentage points to annual organic sales growth.
โ๏ธ Organic operating income margin expanded 70 basis points to 19.6 percent, offsetting higher commodity costs.
๐ Adjusted diluted earnings per share increased 5 percent to $2.18 despite a 10 percent headwind from CoolIT acquisition costs.
๐ญ Ecolab positions its liquid-cooling technologies to benefit from investments in artificial intelligence and data centers.
๐ Stock traded at 277.75 euros, reflecting confidence in the margin-led earnings recovery strategy.
๐ Bullish signals
๐Reported third-quarter sales rose 13 percent year over year to $4.69 billion, demonstrating strong top-line momentum.
๐Organic sales growth accelerated to 7 percent, with volume contributing 2 percent and pricing contributing 5 percent.
๐Global High-Tech organic sales increased significantly by 63 percent, highlighting a major growth engine.
๐Life Sciences organic sales rose 17 percent, providing additional diversification and revenue stability.
๐ปEcolab Digital sales climbed 34 percent to $129 million, showcasing rapid expansion in digital solutions.
โ๏ธOrganic operating income margin expanded 70 basis points to 19.6 percent, indicating improved profitability.
๐ฏManagement expects fourth-quarter reported sales to increase 12 to 14 percent with continued organic growth.
๐Full-year 2026 adjusted diluted earnings per share are forecast at $8.10 to $8.20, an 8 to 9 percent increase.
๐ฎThe company anticipates achieving a 20 percent adjusted operating margin in 2027 as acquisition impacts fade.
๐คAcquisitions Ovivo Electronics and CoolIT are expected to add about two percentage points to annual organic sales growth.
๐ Risk factors
๐Acquisition costs, including amortization and financing from the CoolIT deal, weigh on adjusted earnings by approximately 10 percent.
๐Integration of recent acquisitions continues to affect reported profitability in the short term.
โ๏ธHigher commodity costs and growth investments require pricing and productivity gains to offset margin pressure.
๐Customer disruptions remain an important factor that could impact future revenue realization.
๐Financing costs associated with acquisitions continue to drag on net earnings despite organic growth.
Article
Ecolab Inc. reported a robust third quarter in late September 2026, characterized by accelerated organic sales growth and expanding operating margins as the company enters 2027. Reported third-quarter sales rose 13 percent year over year to $4.69 billion, driven by volume increases of 2 percent and pricing gains of 5 percent. The company highlighted significant momentum in its High-Tech and Life Sciences segments, which served as primary growth engines amidst broader market improvements.
Management provided specific guidance for the fourth quarter and full-year 2026, projecting reported sales growth between 12 to 14 percent and organic sales growth of 6 to 7 percent. For the full year 2026, Ecolab expects adjusted diluted earnings per share to reach $8.10 to $8.20, representing an 8 to 9 percent increase from the prior year. The company anticipates achieving an adjusted operating margin of approximately 20 percent in 2027 as acquisition-related amortization impacts diminish.
Strategic acquisitions, specifically Ovivo Electronics and CoolIT, are expected to contribute roughly two percentage points to annual organic sales growth within a year of closing. While these deals drive future revenue expansion, they currently weigh on reported profitability due to integration costs and financing expenses. The company's focus remains on water efficiency solutions and liquid-cooling technologies to capitalize on investments in artificial intelligence infrastructure and data centers.
Ecolab stock traded at 277.75 euros on November 12, 2026, reflecting investor confidence in the margin-led earnings recovery despite ongoing headwinds from commodity prices and customer disruptions. The operating update strengthens the case for sustained profitability improvements as the company successfully integrates new technologies and navigates macroeconomic factors affecting its industrial base.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Ecolab (ECL) shares recently closed at US$278.97, reflecting modest short-term cooling after a strong three-year run, though the stock remains higher over the past quarter with a 3-year total shareholder return of 58.42%. The company generates annual revenue of US$16.8 billion and net income of US$2.1 billion across its water, institutional, specialty, pest elimination, and life sciences operations.
Analysts currently view Ecolab as undervalued, with a calculated fair value of approximately US$323.71, suggesting the stock is trading about 14% below its intrinsic worth. This valuation gap is driven by growth expectations tied to the 'One Ecolab' initiative, which aims to capture market share gains and implement increased value pricing to improve net margins.
Despite the bullish fair value estimate, the current price-to-earnings ratio of roughly 37x presents a significant premium compared to the US Chemicals industry average of 23.2x and peer group average of 20.5x. Investors face potential valuation risk if sentiment cools or if softer industrial demand persists, which could pressure revenue growth and hinder the anticipated margin recovery narrative.
The primary bullish case relies on successful execution of value pricing and market share expansion, while key risks include customer resistance to trade surcharges and a broader economic slowdown in the industrial sector. The high multiple implies that any deviation from optimistic earnings profiles or growth rates could lead to a sharp re-rating of the stock price.
๐ Shares trade 14% below analyst fair value of US$323.71.
๐ฐ Reported annual revenue reached US$16.8 billion with net income of US$2.1 billion.
๐ 'One Ecolab' initiative aims to expand revenue and improve margins via value pricing.
โ ๏ธ Stock trades at a premium 37x P/E versus industry average of 23.2x.
โ๏ธ Valuation risk exists if industrial demand softens or trade surcharges face resistance.
๐ Ecolab (ECL) shares closed at US$278.97, trading approximately 14% below an analyst fair value estimate of US$323.71.
๐ฐ The company reported annual revenue of US$16.8 billion and net income of US$2.1 billion across its diverse industrial operations.
๐ Ecolab is advancing its 'One Ecolab' growth initiative to drive revenue expansion and improve net margins through value pricing.
โ ๏ธ The stock trades at a premium P/E ratio of 37x, significantly higher than the industry average of 23.2x and peers at 20.5x.
๐ Recent share price momentum has cooled over the past week and month despite a strong 90-day return of 8.14%.
โ๏ธ Investors face valuation risk if softer industrial demand persists or customers resist the proposed trade surcharges.
๐ญ Ecolab operates in water, institutional, specialty, pest elimination, and life sciences sectors with a resilient longer-term trend.
Bullish Signals
Analysts estimate fair value of US$323.71, implying 14% undervaluation.
'One Ecolab' initiative expected to drive revenue growth.
Bullish Signals
Analysts estimate a fair value of US$323.71 for Ecolab, implying the current price of US$278.97 is undervalued by approximately 14%.
The company's 'One Ecolab' initiative is expected to drive revenue growth and improve net margins through successful market share gains and value pricing strategies.
Risk Factors
Ecolab trades at a P/E ratio of roughly 37x, which is substantially higher than the US Chemicals industry average of 23.2x and peer average of 20.5x.
The margin recovery narrative faces risks if customers resist trade surcharges or if softer industrial demand persists in the coming quarters.
Ecolab Inc. reported a solid second-quarter 2026 performance, delivering earnings per share of $2.09 on revenue of $4.42 billion, which topped analyst consensus estimates of $2.08 EPS and $4.38 billion in revenue. This result underscores continued demand for the company's hygiene and water solutions across key end markets, including institutional cleaning, food safety, and industrial water treatment, despite prevailing macroeconomic headwinds.
Management has raised its outlook for the remainder of fiscal year 2026, providing third-quarter EPS guidance between $2.13 and $2.23. This upward revision signals confidence in sustaining operating leverage as pricing actions and efficiency measures flow through the income statement, supporting a longer-term consensus target price of $327.56 that sits above the stock's recent trading levels.
The company maintains its status as a stable income name within the basic materials sector, supported by a quarterly dividend of $0.73 per share declared for 2026. While institutional investors show mixed flows and short interest has increased slightly to 1.2% of the float, the core business model combining proprietary chemistry with on-site service expertise continues to drive recurring revenue and deep customer relationships.
Ecolab's integrated approach allows customers to achieve reduced water usage and lower energy consumption, reinforcing its defensive characteristics across cyclical industries. With the stock trading at $287.06 in late August 2026, investors are watching for sustained mid-teens EPS growth to validate the current valuation gap relative to analyst targets.
๐ Ecolab beat Q2 EPS and revenue expectations with $2.09 EPS and $4.42B revenue.
๐ Management raised full-year outlook with Q3 guidance of $2.13-$2.23 EPS.
๐ฐ Company declared quarterly dividend of $0.73, annualizing to $2.92 per share.
๐ Analysts project 2026 EPS of $8.17 with target price of $327.56.
๐ Short interest rose to 1.2% as some investors anticipate slower growth.
๐ Ecolab beat Q2 2026 expectations with $2.09 EPS and $4.42 billion revenue, surpassing consensus estimates of $2.08 EPS and $4.38 billion.
๐ Management raised full-year outlook with third-quarter guidance set between $2.13 and $2.23 in EPS.
๐ฐ The company declared a quarterly dividend of $0.73 per share for 2026, totaling an annualized payout of $2.92.
๐ Analysts project full-year 2026 EPS of $8.17 with a consensus target price of $327.56.
๐ญ Core business covers institutional cleaning, food safety, and industrial water treatment across diverse end markets.
๐ Short interest increased to 1.2% of float (3.48M shares) as some investors position for slower growth.
๐ง Integrated model delivers recurring revenue through proprietary chemistry, dosing equipment, and on-site service expertise.
๐ Q2 earnings grew year-over-year from $1.89 to $2.09 EPS driven by pricing and cost controls.
๐ก๏ธ Stock trades at a discount to the consensus target, offering potential upside if growth trajectory holds.
๐ Company is a constituent of major US equity benchmarks including the S&P 500.
Bullish Signals
Q2 EPS beat at $2.09 vs $2.08 consensus.
Raised Q3 guidance to $2.13-$2.23 EPS range.
Analysts see $327.56 target price with upside.
Declared $0.73 quarterly dividend for 2026.
Revenue grew in cleaning and water segments.
Risk Factors
Short interest rose to 1.2% with 3.17 days-to-cover.
Stock trades $40 below consensus target price.
Institutions trimmed holdings after earnings release.
Bullish Signals
Ecolab delivered a Q2 2026 earnings beat with $2.09 EPS and $4.42 billion revenue, exceeding consensus estimates of $2.08 EPS and $4.38 billion.
Management raised third-quarter guidance to $2.13-$2.23 EPS, signaling confidence in sustaining operating leverage and margin improvement.
Analysts maintain a full-year 2026 EPS projection of $8.17 with a consensus target price of $327.56, implying significant upside from current levels.
The company declared a quarterly dividend of $0.73 per share for 2026, reinforcing its reputation as a stable income name in the basic materials sector.
Revenue growth reflects solid expansion in institutional cleaning, food safety, and industrial water treatment segments despite macroeconomic headwinds.
Risk Factors
Short interest increased to 1.2% of float (3.48M shares) with a days-to-cover ratio of 3.17, indicating some market skepticism regarding sustained growth.
The stock trades at $287.06, roughly $40 below the consensus target price, reflecting a cautious market stance waiting for proof of sustained mid-teens EPS growth.
Institutional filings show mixed activity with some asset managers trimming holdings, consistent with portfolio rebalancing in response to the earnings release.
Allspring Global Investments Holdings LLC increased its position in Ecolab Inc. (NYSE:ECL) by 4.0% during the first quarter, purchasing an additional 3,727 shares to own a total of 98,004 shares valued at $26.4 million. Several other institutional investors also adjusted their holdings in the fourth quarter, with Universal Beteiligungs und Servicegesellschaft mbH increasing its stake by 25.9% and QRG Capital Management Inc. growing its position by 38.7%. HF Advisory Group LLC saw a massive percentage increase of 1,167.3% in its holding, though the absolute number of shares purchased was significant at 36,723.
Analyst sentiment remains largely positive for Ecolab, with major brokerages including Bank of America, Citigroup, and UBS upgrading their ratings to 'buy' or raising price targets. The consensus rating is a 'Moderate Buy' with an average target price of $324.06, while the stock currently trades around $268.02. Ecolab recently declared a quarterly dividend of $0.73 per share, resulting in an annualized yield of 1.1% and a payout ratio of 39.51%. The company maintains a market capitalization of $75.43 billion with a P/E ratio of 36.27.
Insider trading activity shows mixed signals but net buying over the last quarter, with corporate insiders purchasing shares worth approximately $2.7 million. Director Suzanne M. Vautrinot sold 1,004 shares representing a 7.93% decrease in her position, while EVP Benjamin M. Clark purchased 1,000 shares to increase his stake by over 1,200%. Ecolab operates as a global provider of water, hygiene, and infection prevention solutions serving diverse markets including hospitality, healthcare, and manufacturing.
๐ Allspring added 3,727 shares to reach 98,004 total holdings.
๐ Universal Beteiligungs increased stake by 25.9% to 330,698 shares.
๐ QRG Capital grew position by 38.7% to 22,362 shares.
๐ HF Advisory surged 1,167.3% with 36,723 new shares bought.
๐ฐ Ecolab declared $0.73 dividend with 1.1% annualized yield.
๐ Allspring Global Investments Holdings LLC boosted its Ecolab position by 4.0% in Q1, adding 3,727 shares to a total holding of 98,004 shares.
๐ Universal Beteiligungs und Servicegesellschaft mbH increased its stake by 25.9% in Q4, now owning 330,698 shares valued at $86.67 million.
๐ QRG Capital Management Inc. grew its Ecolab position by 38.7% in the fourth quarter to own 22,362 shares.
๐ HF Advisory Group LLC significantly increased its holdings by 1,167.3% in Q4, purchasing an additional 36,723 shares.
๐ฐ Ecolab declared a quarterly dividend of $0.73 per share with an ex-dividend date of June 16th and an annualized yield of 1.1%.
๐ Bank of America raised its price target to $345.00 and maintained a 'buy' rating in a recent research report.
๐ Citigroup lifted its price objective from $325.00 to $330.00 and assigned a 'buy' rating on Wednesday, June 24th.
๐ UBS Group upgraded Ecolab from 'neutral' to 'buy' and raised its target price from $293.00 to $325.00.
๐ Director Suzanne M. Vautrinot sold 1,004 shares for a total value of $266,039.92 in a transaction dated May 27th.
๐ EVP Benjamin M. Clark purchased 1,000 shares at an average cost of $263.83, increasing his position by over 1,200%.
๐ผ Corporate insiders have net purchased 10,550 shares worth $2.7 million over the last quarter.
๐ The stock currently trades at a P/E ratio of 36.27 with a market cap of $75.43 billion and a beta of 0.89.
Bullish Signals
Bank of America raised target to $345.00 with 'buy' rating.
Citigroup lifted objective to $330.00 and issued 'buy' rating.
UBS upgraded to 'buy' and raised target to $325.00.
Insiders net purchased 10,550 shares worth $2.7 million.
EVP Clark increased stake by 1,204.82% buying 1,000 shares.
Risk Factors
Director sold 1,004 shares, reducing position by 7.93%.
Stock trades below 200-day moving average of $273.11.
Bullish Signals
Allspring Global Investments Holdings LLC increased its position in Ecolab by 4.0% during the first quarter, adding 3,727 shares to its holdings.
Universal Beteiligungs und Servicegesellschaft mbH significantly increased its stake by 25.9% in the fourth quarter, purchasing an additional 68,062 shares.
QRG Capital Management Inc. grew its position by 38.7% in Q4, acquiring an additional 6,238 shares of Ecolab stock.
HF Advisory Group LLC boosted its position by 1,167.3% in the fourth quarter, buying an additional 36,723 shares.
Bank of America raised its price target on Ecolab from $337.00 to $345.00 and reaffirmed a 'buy' rating.
Citigroup lifted its price objective from $325.00 to $330.00 and issued a 'buy' rating in a recent report.
UBS Group upgraded Ecolab from a 'neutral' rating to a 'buy' and raised its target price from $293.00 to $325.00.
Corporate insiders have net purchased 10,550 shares worth approximately $2.7 million over the last quarter.
EVP Benjamin M. Clark increased his personal stake by 1,204.82% by purchasing 1,000 shares of company stock.
Risk Factors
Director Suzanne M. Vautrinot sold 1,004 shares of Ecolab stock, representing a 7.93% decrease in her personal position.
The stock is trading below its 200-day moving average of $273.11 and has recently hit a twelve-month low of $243.15.
Copeland Capital Management LLC established a new position in Ecolab Inc. (NYSE:ECL) during the first quarter, purchasing 33,115 shares valued at approximately $8.81 million. This move joins several other major institutional investors who increased their stakes in the fourth quarter, including Vanguard Group, JPMorgan Chase, Morgan Stanley, Geode Capital Management, and Capital World Investors, collectively reinforcing strong institutional ownership at 74.91%.
Analyst sentiment remains mixed but generally positive regarding Ecolab's fundamentals. While Robert W. Baird and Jefferies Financial Group lowered their price targets to $296 and $345 respectively, Citigroup raised its target to $330 with a buy rating. The consensus rating is a Moderate Buy with a target price of $324.06, though the stock recently traded near its 52-week low of $243.15.
Financially, Ecolab reported strong quarterly performance with revenue of $4.07 billion, beating estimates by $40 million and representing a 10% year-over-year increase. The company posted earnings per share of $1.70, matching analyst expectations, while maintaining a net margin of 12.80% and a return on equity of 22.64%. Management has provided guidance for FY 2026 EPS between $8.43 and $8.63.
The company continues to distribute dividends with a recent payment of $0.73 per share, yielding 1.1% annually based on the current price. However, insider activity shows some executives reducing their holdings; COO Darrell R. Brown sold 10,000 shares and Director Suzanne M. Vautrinot sold 1,004 shares, though net insider purchases over the last three months totaled $2.72 million.
๐ Copeland Capital bought 33,115 shares worth $8.81 million in Q1.
๐ฐ Revenue hit $4.07 billion, beating estimates with 10% growth.
๐ Major institutions like Vanguard and JPMorgan increased holdings in Q4.
๐ฆ Net margin is 12.80% with ROE of 22.64%.
๐ฏ Analysts rate it Moderate Buy with a $324.06 target price.
๐ Copeland Capital Management LLC initiated a new position in Ecolab by buying 33,115 shares valued at approximately $8.81 million in the first quarter.
๐ Major institutional investors including Vanguard, JPMorgan Chase, and Morgan Stanley increased their holdings of Ecolab stock during the fourth quarter.
๐ฐ Ecolab reported quarterly revenue of $4.07 billion, surpassing analyst estimates of $4.03 billion with a 10% year-over-year growth rate.
๐ The company posted earnings per share of $1.70, which exactly matched the consensus estimate of $1.70 for the quarter.
๐ฆ Ecolab maintains a net margin of 12.80% and a return on equity of 22.64%, demonstrating strong profitability metrics.
๐ Management provided forward guidance for FY 2026 EPS ranging from $8.43 to $8.63, slightly above the average analyst expectation of $8.13.
๐ต The company paid a quarterly dividend of $0.73 per share on July 15th, resulting in an annualized yield of 1.1%.
๐ COO Darrell R. Brown sold 10,000 shares worth $2.61 million, representing a 23.40% decrease in his personal position.
๐ Director Suzanne M. Vautrinot sold 1,004 shares worth $266,039, reducing her direct ownership by 7.93%.
๐ Net insider buying over the last three months totaled $2.72 million, indicating some executives are accumulating stock despite recent sales.
๐ฏ The consensus analyst rating is Moderate Buy with a target price of $324.06, though individual targets vary from $295 to $330.
๐ Ecolab stock opened at $272.91 and has a 52-week low of $243.15 against a high of $309.27.
Bullish Signals
Vanguard increased stake to 25M shares.
JPMorgan grew position by 63.1%.
Ecolab beat revenue with $4.07B.
Net margin reached 12.80%.
Citi raised target to $330.
Risk Factors
COO sold 10k shares worth $2.61M.
Director sold 1k shares worth $266k.
Baird lowered target to $296.
Weiss downgraded stock in May.
Stock trades near 52-week low of $243.
Bullish Signals
Copeland Capital Management LLC initiated a new position in Ecolab, signaling confidence from a dedicated capital manager.
Vanguard Group increased its stake by 0.5% to own over 25 million shares, reflecting continued institutional support.
JPMorgan Chase significantly grew its position by 63.1%, acquiring over 4.1 million shares in the fourth quarter.
Ecolab beat revenue expectations with $4.07 billion reported versus $4.03 billion estimated by analysts.
The company achieved a net margin of 12.80% and a return on equity of 22.64%, indicating efficient capital use.
Revenue grew 10% year-over-year, demonstrating strong top-line expansion in the basic materials sector.
Management guidance for FY 2026 EPS ($8.43-$8.63) exceeds the average analyst forecast of $8.13.
Citigroup raised its price target to $330 and maintained a buy rating, supporting bullish sentiment.
Net insider purchases over the last three months reached $2.72 million, showing executive accumulation.
Risk Factors
COO Darrell R. Brown sold 10,000 shares worth $2.61 million, reducing his position by 23.40%.
Director Suzanne M. Vautrinot sold 1,004 shares worth $266,039, decreasing her stake by 7.93%.
Robert W. Baird lowered its price target from $320 to $296 despite maintaining an outperform rating.
Jefferies Financial Group reduced its price target from $352 to $345 while keeping a buy rating.
Weiss Ratings downgraded the stock from a 'buy (b)' to a 'buy (b-)' rating in May.
The stock is trading near its 52-week low of $243.15, suggesting recent market weakness or lack of momentum.
Analyst consensus target price of $324.06 is below the 52-week high of $309.27, indicating limited upside from current levels if trading near lows.
Oppenheimer upgraded Ecolab (NYSE:ECL) to an Outperform rating with a $320 price target, joining a broader consensus of positive analyst sentiment including recent upgrades from UBS and Citigroup. The stock currently holds a 'Moderate Buy' consensus rating with a collective price target of $324.06, reflecting strong institutional confidence in the basic materials company's operational performance.
Ecolab reported Q1 2026 earnings on April 28th that met analyst expectations, delivering $1.70 EPS and revenue of $4.07 billion, a 10% year-over-year increase. The company demonstrated robust profitability with a 22.64% return on equity and a 12.80% net margin, while setting forward guidance for FY 2026 EPS between $8.43 and $8.63.
The company recently paid a quarterly dividend of $0.73 per share, resulting in an annualized yield of 1.1% with a payout ratio of 39.51%. Institutional ownership remains high at 74.91%, with major holders like Vanguard and JPMorgan Chase increasing their stakes in the fourth quarter, signaling continued interest from large capital managers.
๐ Analysts upgraded Ecolab with price targets ranging from $320 to $330.
๐ฐ Q1 2026 EPS hit $1.70 on $4.07B revenue, a 10% year-over-year increase.
๐ FY 2026 guidance of $8.43โ$8.63 beats the consensus estimate of $8.13.
๐ธ Quarterly dividend of $0.73 paid on July 15th with a 1.1% yield.
๐ฆ Institutional ownership is 74.91%, showing net insider buying despite executive sales.
๐ Oppenheimer upgraded Ecolab to Outperform with a $320 price target following strong quarterly results.
๐ UBS raised its rating to Buy and lifted the price target to $325, while Citigroup increased its objective to $330.
๐ฐ Ecolab reported Q1 2026 EPS of $1.70, matching consensus estimates on revenue of $4.07 billion.
๐ Revenue grew 10% year-over-year, driven by growth in hospitality, foodservice, and healthcare sectors.
๐น The company achieved a 22.64% return on equity and maintained a healthy 12.80% net margin.
๐ Management set FY 2026 EPS guidance between $8.43 and $8.63, exceeding analyst consensus of $8.13.
๐ธ A quarterly dividend of $0.73 was paid on July 15th with an annualized yield of 1.1%.
๐ฆ Institutional ownership stands at 74.91%, with Vanguard and JPMorgan Chase increasing holdings in Q4.
๐ COO Darrell Brown sold shares, while EVP Benjamin Clark purchased stock, resulting in net insider buying.
๐ Ecolab provides water, hygiene, and infection prevention solutions across global end markets.
Bullish Signals
Oppenheimer upgraded to Outperform with $320 target.
Q1 2026 earnings beat with $4.07B revenue.
22.64% ROE and 12.80% net margin delivered.
FY 2026 EPS guidance of $8.43-$8.63 beats.
Vanguard and JPMorgan increased stakes in Q4.
Risk Factors
COO sold 10,000 shares worth $2.6 million.
Analyst consensus price target of $324.06.
Bullish Signals
Oppenheimer upgraded the stock to Outperform with a $320 price target, aligning with recent upgrades from UBS and Citigroup.
Q1 2026 earnings beat expectations with revenue of $4.07 billion representing a 10% year-over-year increase.
The company delivered strong profitability metrics including a 22.64% return on equity and a 12.80% net margin.
FY 2026 guidance of $8.43-$8.63 EPS exceeds the sell-side consensus estimate of $8.13.
Major institutional investors like Vanguard and JPMorgan Chase increased their stakes in the fourth quarter.
The company maintains a sustainable dividend yield of 1.1% with a payout ratio of 39.51%.
Risk Factors
COO Darrell Brown sold 10,000 shares worth $2.6 million, representing a 23.40% decrease in his personal ownership.
Analyst consensus price target of $324.06 is slightly below Oppenheimer's new $320 target but reflects mixed short-term sentiment.
Ecolab (ECL) has been removed from several Russell growth benchmarks, including the Russell 1000 Growth and Russell Top 200 Growth indices. This technical shift has triggered index-related selling and necessitates portfolio adjustments for investors holding funds tied to these specific indexes.
Despite the index removal, Ecolab's share price momentum remains firm, with an 8.83% gain over the past month and a year-to-date return of 6.08%. The company is actively expanding its 'One Ecolab' growth initiative, which aims to capture market share gains and implement value pricing strategies to drive revenue expansion and improve net margins.
Analyst sentiment presents a mixed picture regarding valuation. While one narrative suggests the stock is 12.2% undervalued with a fair value estimate of $317.14 versus the current price of $278.60, the company trades at a premium P/E ratio of 37.2x compared to the US Chemicals industry average of 24.6x and peer average of 23.6x.
The high valuation multiple implies that future performance must justify the premium; otherwise, investors face downside risk if growth or margins disappoint. Key risks include potential weakness in heavy industrial demand and customer resistance to surcharges or price increases, which could pressure both volumes and profit margins.
๐ Ecolab removed from Russell 1000 Growth indices.
๐ Stock up 8.83% to $278.60 vs $317.38 target.
๐ฐ 3-year return of 54.06% beats 1-year return of 4.50%.
โ ๏ธ High P/E of 37.2x creates downside risk if growth slows.
๐ญ Industrial demand weakness threatens volumes and business performance.
๐ Ecolab (ECL) has been removed from the Russell 1000 Growth and Russell Top 200 Growth indices, prompting index-related selling.
๐ The stock gained 8.83% over the past month and is trading at $278.60 against an average analyst price target of $317.38.
๐ฐ Ecolab's 3-year total shareholder return of 54.06% significantly outperforms its 1-year return of 4.50%, indicating a longer-term build-up.
๐ The company is launching the 'One Ecolab' growth initiative to capitalize on market share gains and increased value pricing.
โ๏ธ A popular narrative pegs fair value at $317.14, suggesting the stock is currently 12.2% undervalued based on historical data.
๐ Ecolab trades at a P/E ratio of 37.2x, which is substantially higher than the US Chemicals industry average of 24.6x and peer average of 23.6x.
โ ๏ธ The high valuation premium creates downside risk if earnings fail to track expectations or if growth slows.
๐ญ Heavy industrial demand weakness could negatively impact Ecolab's volumes and overall business performance.
๐ธ Customer resistance to surcharges and price increases poses a direct threat to the company's net margins.
๐ The index removal may signal a rotation of capital away from growth stocks, though fundamentals remain mixed.
Bullish Signals
Stock rose 8.83% this month with 6.08% year-to-date gain.
Three-year total return of 54.06% shows strong long-term performance.
Analysts see undervaluation at $278.60 vs $317.38 average target.
One Ecolab initiative drives revenue and margin expansion.
Risk Factors
P/E of 37.2x is significantly above industry average of 24.6x.
Industrial demand weakness could pressure volumes and revenue generation.
Customer resistance to price hikes may directly impact net margins.
High valuation implies significant downside risk on growth disappointment.
Bullish Signals
Ecolab has demonstrated firm momentum with an 8.83% share price increase over the past month and a year-to-date return of 6.08%.
The company's 3-year total shareholder return of 54.06% is well ahead of its 1-year return, suggesting a solid long-term performance track record.
Analyst consensus indicates the stock is potentially undervalued at $278.60 compared to an average price target of $317.38 and a narrative fair value of $317.14.
Ecolab is executing its 'One Ecolab' growth initiative to drive revenue expansion and improve net margins through market share gains.
Risk Factors
The stock trades at a P/E ratio of 37.2x, significantly above the US Chemicals industry average of 24.6x and peer average of 23.6x, creating valuation risk.
Heavy industrial demand weakness could put pressure on Ecolab's volumes and overall revenue generation.
Customers may resist surcharges and price increases, which would directly impact the company's net margins.
The high premium valuation implies that any disappointment in growth or margin performance could lead to significant downside risk.
Shares of Ecolab Inc. (NYSE:ECL) have received an average analyst recommendation of 'Moderate Buy' based on ratings from twenty-one firms, with seventeen analysts rating it a buy and three holding. The consensus 12-month price target stands at approximately $323.71. Recent activity includes UBS upgrading the stock to 'buy' with a $325 target and Royal Bank of Canada maintaining an 'outperform' rating at $337, while JPMorgan Chase upgraded it to 'overweight' at $295.
Ecolab reported strong quarterly financial results ending April 28th, posting earnings per share (EPS) of $1.70 which matched analyst consensus estimates. Revenue reached $4.07 billion, slightly beating the $4.03 billion forecast and representing a 10% year-over-year increase. The company demonstrated robust profitability with a net margin of 12.80% and a return on equity of 22.64%. Management has provided forward guidance for fiscal 2026 EPS between $8.43 and $8.63.
The company recently declared a quarterly dividend of $0.73 per share, payable on July 15th to shareholders of record on June 16th, resulting in an annualized yield of 1.0%. Insider trading activity saw Director Michel D. Doukeris purchase 7,750 shares worth nearly $2 million, increasing his position significantly, while COO Darrell R. Brown sold 10,000 shares. Institutional ownership remains high at 74.91%, with several asset management firms adding new stakes during the first three quarters of the year.
๐ Analysts rate Ecolab 'Moderate Buy' with $323.71 price target.
๐ UBS upgraded to 'buy' raising target to $325.
๐ฐ Q1 EPS hit $1.70 on $4.07B revenue growth of 10%.
๐ Net margin reached 12.80% with ROE of 22.64%.
๐ฎ Fiscal 2026 EPS guidance ranges from $8.43 to $8.63.
๐ Ecolab received an average 'Moderate Buy' rating from twenty-one analysts with a consensus 12-month price target of $323.71.
๐ UBS upgraded Ecolab to 'buy' and raised its price target to $325, while Royal Bank of Canada set a target of $337.
๐ฐ The company reported Q1 EPS of $1.70, matching analyst estimates on revenue of $4.07 billion which grew 10% year-over-year.
๐ Ecolab achieved a net margin of 12.80% and a return on equity of 22.64% during the reported quarter.
๐ฎ Management guidance for fiscal 2026 EPS ranges from $8.43 to $8.63, with analysts expecting $8.47.
๐ต A quarterly dividend of $0.73 was declared, offering a 1.0% annualized yield to shareholders of record on June 16th.
๐ Director Michel D. Doukeris purchased 7,750 shares for approximately $2 million, increasing his stake by over 1,300%.
๐ COO Darrell R. Brown sold 10,000 shares for roughly $2.6 million, reducing his position by 23.4%.
๐ฆ Institutional investors hold 74.91% of the company's stock, with multiple firms adding new stakes in recent quarters.
๐ Ecolab operates globally providing water, hygiene, and infection prevention solutions across hospitality, healthcare, and industrial sectors.
Bullish Signals
Analysts issue 'Moderate Buy' consensus based on strong fundamentals.
UBS upgrades to 'buy' with $325 price target.
Royal Bank of Canada maintains 'outperform' at $337 target.
JPMorgan Chase upgrades to 'overweight' with $295 target.
Revenue beats estimates at $4.07 billion vs $4.03 billion.
Earnings per share of $1.70 match analyst consensus exactly.
Revenue grows 10% year-over-year to $4.07 billion.
Net margin reaches 12.80% with 22.64% return on equity.
Director purchases nearly $2 million in shares.
Institutional ownership stands robust at 74.91%.
Risk Factors
Robert W. Baird cut price target from $320 to $296.
Jefferies Financial Group lowered price target from $352 to $345.
COO Darrell R. Brown sold 10,000 shares worth $2.6 million.
Bullish Signals
Analysts have issued a 'Moderate Buy' consensus recommendation based on strong fundamentals and positive outlooks.
UBS upgraded the stock to 'buy' and increased its price target to $325, reflecting improved confidence in the business.
Royal Bank of Canada maintained an 'outperform' rating with a high price target of $337.
JPMorgan Chase upgraded Ecolab to 'overweight' with a price target of $295.
The company beat revenue expectations, reporting $4.07 billion against a consensus estimate of $4.03 billion.
Earnings per share of $1.70 matched analyst consensus exactly, demonstrating execution reliability.
Adams Natural Resources Fund Inc. reduced its position in Ecolab Inc. (NYSE:ECL) by 25.9% in the first quarter, selling 11,000 shares to hold a remaining stake of 31,400 shares valued at $8.35 million. While Adams lowered its exposure, several major institutional investors increased their holdings during the fourth quarter. Vanguard Group Inc. added 137,578 shares, JPMorgan Chase & Co. boosted its stake by 63.1%, and Morgan Stanley, Geode Capital Management LLC, and Capital World Investors also purchased additional shares.
Analyst sentiment remains positive with multiple upgrades and price target increases recently issued for Ecolab stock. Berenberg Bank upgraded the rating to 'buy' with a $326.00 objective, while Royal Bank of Canada, Bank of America, JPMorgan Chase & Co., and Deutsche Bank Aktiengesellschaft also raised targets or ratings. The consensus average rating is 'Moderate Buy' with a collective target price of $323.71, suggesting continued confidence in the company's fundamentals despite some insider selling.
Ecolab reported strong quarterly financial results on April 28th, beating analyst estimates for earnings per share and revenue. The company posted $1.70 EPS against a consensus of $1.70 and generated $4.07 billion in revenue, representing a 10% year-over-year increase. Management has provided forward guidance for fiscal year 2026 EPS between $8.43 and $8.63, with analysts expecting the company to achieve $8.47 EPS for the current fiscal year.
The company maintains a solid dividend profile with an upcoming payment of $0.73 per share on July 15th for shareholders of record on June 16th. This represents a yield of 1.0% and a payout ratio of 39.51%. Ecolab operates as a global provider of water, hygiene, and infection prevention solutions across diverse end markets including hospitality, healthcare, manufacturing, and energy sectors.
๐ Adams Natural Resources Fund sold 11,000 shares, reducing stake by 25.9%.
๐ JPMorgan Chase boosted Ecolab stake by 63.1% to 4.1 million shares.
๐ฐ Q1 revenue hit $4.07 billion, a 10% year-over-year increase.
๐ผ Berenberg Bank upgraded stock to 'buy' with $326 price target.
๐ Stock trades at P/E of 38.39 with $79.85 billion market cap.
๐ Adams Natural Resources Fund Inc. sold 11,000 shares of Ecolab in Q1, reducing its stake by 25.9% to 31,400 shares.
๐ Vanguard Group Inc. increased its Ecolab position by 0.5% to own 25.3 million shares valued at $6.65 billion.
๐ JPMorgan Chase & Co. significantly boosted its stake by 63.1%, purchasing an additional 4.1 million shares.
๐ Morgan Stanley, Geode Capital Management LLC, and Capital World Investors all added to their Ecolab holdings in Q4.
๐ผ Berenberg Bank upgraded Ecolab to a 'buy' rating with a $326.00 price objective on March 16th.
๐ผ Bank of America raised its target price from $337.00 to $345.00 and maintained a 'buy' rating in April.
๐ฐ Revenue reached $4.07 billion for the quarter, marking a 10% increase compared to the previous year.
๐ The company announced a quarterly dividend of $0.73 per share payable on July 15th.
๐ฉโ๐ผ Director Suzanne Vautrinot sold 1,004 shares while COO Darrell Brown sold 10,000 shares recently.
๐ The stock trades at a P/E ratio of 38.39 with a market capitalization of $79.85 billion.
๐ฏ Analyst consensus target price stands at $323.71 with an average rating of 'Moderate Buy'.
Bullish Signals
Major institutions increased stakes in Q4.
Ecolab beat revenue: $4.07B vs $4.03B estimate.
Analysts raised targets to $326-$345.
Net margin 12.80% and ROE 22.64%.
FY 2026 EPS guidance $8.43-$8.63.
Dividend yield 1.0% with 39.51% payout.
Risk Factors
Insiders sold shares: Director Vautrinot -7.93%, COO Brown -23.40%.
High valuation: P/E 38.39, PEG 2.35.
Bullish Signals
Major institutional investors including Vanguard, JPMorgan Chase, Morgan Stanley, and Capital World Investors increased their stakes in Ecolab during the fourth quarter.
Ecolab beat revenue expectations by reporting $4.07 billion versus analyst estimates of $4.03 billion for the first quarter.
Multiple sell-side analysts have upgraded the stock or raised price targets, including Berenberg Bank ($326), Royal Bank of Canada ($337), and Bank of America ($345).
The company achieved a net margin of 12.80% and a return on equity of 22.64% in the most recent quarter.
Management provided clear forward guidance for FY 2026 EPS between $8.43 and $8.63, aligning closely with analyst expectations of $8.47.
The stock maintains a consistent dividend yield of 1.0% with a sustainable payout ratio of 39.51%.
Risk Factors
Corporate insiders sold shares recently, with Director Suzanne Vautrinot reducing her position by 7.93% and COO Darrell Brown decreasing his stake by 23.40%.
The stock trades at a premium valuation with a price-to-earnings ratio of 38.39 and a PEG ratio of 2.35.
On June 24, 2026, Citigroup raised its price target for Ecolab Inc. (NYSE: ECL) to $330 from $325 while maintaining a Buy rating. The firm designated Ecolab as its top pick in the specialty chemicals sector ahead of the upcoming second-quarter earnings season, placing the stock on an 'upside 90-day catalyst watch.' Analyst Patrick Cunningham highlighted that easing raw material costs will significantly benefit the company.
Citi's research note emphasizes that Ecolab's 'mission-critical' product portfolio positions it well to convert temporary surcharges into structural pricing power. Concurrently, Wells Fargo raised its price goal for ECL to $275 from $260 on June 10, maintaining an Equal Weight rating. During a meeting with Investor Relations executive Andy Hedberg at the Industrials Conference, analysts were encouraged by management's confidence in offsetting commodity cost pressures through its energy surcharge mechanism.
Wells Fargo specifically noted that Ecolab's growth engines, particularly within its High-Tech business segment, continue to drive overall company growth. The article underscores a dual narrative of analyst optimism regarding pricing power and operational resilience against input costs, though it concludes with a promotional pitch for other AI stocks unrelated to the core financial analysis of Ecolab.
๐ Citi raised ECL price target to $330 on June 24, 2026.
๐ Citi reiterated Buy rating and named Ecolab top specialty chemical pick.
โก Easing raw material costs identified as primary driver for near-term upside.
๐ฐ Firm believes Ecolab can convert surcharges into structural pricing power.
๐ Wells Fargo raised price goal to $275 on June 10.
๐ Citigroup raised its price target for Ecolab (ECL) to $330 from $325 on June 24, 2026.
๐ Citi reiterated a Buy rating and named Ecolab the top specialty chemicals pick ahead of Q2 earnings.
โก Analyst Patrick Cunningham identified easing raw material costs as a primary driver for Ecolab's near-term upside.
๐ฐ The firm believes Ecolab can convert surcharges into structural pricing due to its mission-critical product mix.
๐ Wells Fargo raised its price goal to $275 from $260 on June 10, maintaining an Equal Weight rating.
๐ค Wells Fargo executives expressed confidence in Ecolab's ability to offset commodity cost pressures via energy surcharges.
๐ The High-Tech business segment is highlighted as a key growth engine driving the company forward.
๐ Ecolab is currently under an 'upside 90-day catalyst watch' by Citigroup analysts.
Bullish Signals
Citigroup raised price target to $330.
Analysts see structural pricing power from surcharges.
Wells Fargo increased goal to $275.
Management offsets rising costs via energy surcharges.
Ecolab is a top specialty chemicals pick.
Bullish Signals
Citigroup raised its price target to $330, signaling strong institutional confidence in the stock's valuation ahead of earnings.
Analysts believe Ecolab's mission-critical products allow it to successfully convert surcharges into permanent structural pricing power.
Wells Fargo increased its price goal to $275 and noted that the High-Tech business continues to serve as a primary growth driver.
Management demonstrated confidence in offsetting rising commodity costs through established energy surcharge mechanisms.
Ecolab is positioned as a top pick in the specialty chemicals sector by major investment banks.
Ecolab (ECL) stock recently closed at US$276.29, reflecting gains of 2.7% over the past week and 9.1% over the last month. The article analyzes whether these recent price movements offer genuine value by comparing current market levels against fundamental valuation models, specifically highlighting a significant premium to intrinsic value estimates.
Using a two-stage Free Cash Flow to Equity (DCF) model, Simply Wall St calculates an estimated intrinsic value of approximately US$207.51 per share. This implies the stock is trading at a premium of roughly 33.1% above its calculated fair value based on projected future cash flows, which are expected to grow from $2.0 billion in the latest twelve months to $2.47 billion by 2028.
The analysis further examines the Price-to-Earnings (P/E) ratio, noting Ecolab trades at 36.93x earnings compared to a peer group average of 23.26x and a proprietary 'Fair Ratio' estimate of 24.70x. While the company provides water, hygiene, and infection prevention solutions, the valuation metrics suggest the stock is priced above fair value relative to both industry peers and specific fundamental models.
The article concludes that while Ecolab remains a major player in operational efficiency and resource management, current pricing appears stretched versus cash flow and earnings models. It suggests investors should consider alternative narratives regarding future revenue, margins, and risks like tariffs or demand softness before assuming the high valuation is justified.
๐ Ecolab rose 9.1% this month to close at US$276.29.
๐ฐ Twelve-month free cash flow is $2.0 billion, growing to $2.47B by 2028.
๐ DCF model values stock at US$207.51, implying a 33.1% premium.
๐ P/E ratio of 36.9x is significantly higher than peer average of 23.3x.
โ ๏ธ Valuation score of 0/6 indicates the stock looks pricey versus models.
๐ Ecolab (ECL) recently closed at US$276.29, marking a 2.7% gain over the past week and 9.1% over the last month.
๐ฐ The company's latest twelve-month Free Cash Flow is approximately $2.0 billion with projections reaching $2.47 billion by 2028.
๐ A Discounted Cash Flow (DCF) model estimates an intrinsic value of US$207.51 per share, implying the stock is trading 33.1% above fair value.
๐ Ecolab currently trades at a P/E ratio of 36.93x, significantly higher than its peer group average of 23.26x and a proprietary fair ratio of 24.70x.
โ ๏ธ The article identifies a valuation score of 0 out of 6, indicating the stock looks pricey versus cash flow and earnings models.
๐ญ Ecolab operates as a major provider of water, hygiene, and infection prevention solutions in the United States and internationally.
๐ Analyst estimates project intermediate Free Cash Flow growth to $1.87 billion in 2026 and $2.40 billion in 2027.
๐ฃ๏ธ The analysis suggests investors should weigh bullish narratives around pricing power against risks like softer demand and integration challenges.
Bullish Signals
Ecolab leads water and hygiene sectors with strong operational efficiency.
Consistent growth: 57.4% return in 3 years, 41.8% in 5 years.
Risk Factors
DCF analysis suggests stock is overvalued by approximately 33.1%.
P/E ratio of 36.93x exceeds peer average of 23.26x.
Free Cash Flow projected at $1.87B in 2026 and $2.40B in 2027.
Bullish Signals
Ecolab is a major player in the water, hygiene, and infection prevention sectors with a strong focus on operational efficiency and resource management.
The company has demonstrated consistent long-term growth with a 57.4% return over three years and a 41.8% return over five years.
Risk Factors
Valuation models indicate the stock is trading at a significant premium, with a DCF analysis suggesting it is overvalued by approximately 33.1%.
The current P/E ratio of 36.93x is substantially higher than the peer group average of 23.26x and the proprietary fair ratio estimate of 24.70x.
Analyst forecasts for Free Cash Flow growth are moderate, with projections of $1.87 billion in 2026 and $2.40 billion in 2027.
Institutional ownership of Ecolab Inc. (NYSE:ECL) saw significant shifts in the first quarter, highlighted by a sharp reduction from BI Asset Management Fondsmaeglerselskab A S, which cut its stake by 79.3% to hold just 22,767 shares worth $6.056 million. Conversely, major institutions like JPMorgan Chase & Co. increased their positions substantially, with JPMorgan raising its stake by 63.1% to own over 10.6 million shares valued at approximately $2.788 billion. Other notable new or increased stakes include Capital World Investors, Norges Bank, and Janus Henderson Group PLC, while Auto Owners Insurance Co saw a massive percentage increase in holdings.
The company recently reported strong quarterly financial results for the period ending April 28th, posting earnings per share (EPS) of $1.70 which met analyst consensus estimates. Revenue reached $4.07 billion, representing a 10% year-over-year increase compared to expectations of $4.03 billion. The firm achieved a net margin of 12.80% and a return on equity of 22.64%. Looking ahead, Ecolab has provided guidance for fiscal year 2026 EPS between $8.43 and $8.63, with Q2 2026 guidance set between $2.02 and $2.12.
Analyst sentiment remains generally positive following recent upgrades from Deutsche Bank and UBS, both of which raised their price targets to $325. The consensus price target across the market is currently $323.41 with a 'Moderate Buy' rating. Ecolab also announced a quarterly dividend of $0.73 per share payable on July 15th for shareholders of record on June 16th, maintaining an annualized yield of 1.1% and a payout ratio of 39.51%. Insider trading activity included Director Michel D. Doukeris purchasing shares while Director Suzanne M. Vautrinot sold a small portion of her holdings.
๐ BI Asset Management sold 87,381 shares, retaining only 22,767.
๐ JPMorgan Chase increased stake by 63.1% to 10.6 million shares.
๐ฐ Capital World and Norges Bank added $1.02B and $880M stakes.
๐ Q1 EPS hit $1.70 with revenue up 10% to $4.07B.
๐ Deutsche Bank and UBS upgraded Ecolab to 'buy' at $325 target.
๐ BI Asset Management Fondsmaeglerselskab A S reduced its Ecolab holdings by 79.3% in Q1, selling 87,381 shares to retain only 22,767 shares.
๐ JPMorgan Chase & Co. increased its stake by 63.1% in Q4, now owning over 10.6 million shares valued at $2.788 billion.
๐ฐ Capital World Investors and Norges Bank established new stakes worth approximately $1.02 billion and $880 million respectively during the fourth quarter.
๐ Ecolab reported Q1 EPS of $1.70, matching analyst estimates, with revenue rising 10% year-over-year to $4.07 billion.
๐ฏ The company provided FY 2026 guidance of $8.43-$8.63 EPS and Q2 2026 guidance of $2.02-$2.12 EPS.
๐ต A quarterly dividend of $0.73 per share will be paid on July 15th to shareholders of record on June 16th.
๐ Deutsche Bank and UBS upgraded Ecolab to 'buy' ratings with a unified price target of $325.
๐ Auto Owners Insurance Co increased its position by 26,152% in Q4, acquiring an additional 941,472 shares.
๐ค Director Michel D. Doukeris purchased 7,750 shares at $258/share, increasing his personal stake significantly.
๐ Hedge funds and other institutional investors collectively own 74.91% of the company's outstanding stock.
Bullish Signals
Revenue beat expectations by $40 million at $4.07 billion.
Net margin reached 12.80% with ROE of 22.64%.
Revenue grew 10% year-over-year in basic materials sector.
Analysts upgraded to buy with price targets near $325.
Institutional investors like JPMorgan are increasing exposure.
Healthy dividend yield of 1.1% with 39.51% payout ratio.
Risk Factors
BI Asset reduced position by 79.3%.
Weiss Ratings downgraded to buy (b-).
Baird lowered price objective to $296.
Auto Owners increase limited by small base.
Bullish Signals
Ecolab reported revenue of $4.07 billion for the quarter, beating analyst expectations of $4.03 billion by $40 million.
The company achieved a net margin of 12.80% and a return on equity of 22.64%, indicating strong profitability.
Revenue grew 10% year-over-year, demonstrating continued top-line expansion in the basic materials sector.
Deutsche Bank upgraded Ecolab from 'hold' to 'buy' with a price objective of $325.00.
UBS Group raised its price target to $325.00 and upgraded the rating from 'neutral' to 'buy'.
The consensus analyst price target is $323.41, suggesting potential upside from current levels.
Major institutional investors like JPMorgan Chase & Co. and Norges Bank are increasing their exposure to the stock.
Ecolab maintains a healthy dividend yield of 1.1% with a sustainable payout ratio of 39.51%.
Risk Factors
BI Asset Management Fondsmaeglerselskab A S significantly reduced its position by 79.3%, indicating a lack of confidence from this specific institutional investor.
Weiss Ratings lowered its rating from 'buy (b)' to 'buy (b-)', suggesting a slight downgrade in credit or investment quality.
Robert W. Baird reduced its price objective from $320.00 to $296.00, indicating some analysts see limited upside at current valuations.
Auto Owners Insurance Co's massive percentage increase in holdings (26,152%) is driven by a very small base of 945,072 shares, limiting the overall impact on institutional ownership concentration.
Ecolab Inc. (NYSE: ECL) Executive Vice President of Global Supply Chain, Benjamin M. Clark, executed an open-market purchase of 1,000 shares of common stock on June 11, 2026. The transaction was conducted via multiple trades with a weighted average purchase price of $263.831 per share, ranging between $263.800 and $263.840.
Following this acquisition, Clark's direct beneficial ownership in Ecolab common stock increased to 1,082.581 shares. The filing is a Form 4 submitted to the SEC pursuant to Section 16(a) of the Securities Exchange Act of 1934, disclosing changes in beneficial ownership for officers and directors.
This insider buying activity signals confidence from a high-level executive regarding the company's current valuation and future prospects. Open-market purchases by insiders are often viewed positively by investors as they indicate that management believes the stock is undervalued or well-positioned relative to its peers.
๐ EVP Benjamin M. Clark bought 1,000 shares on June 11, 2026.
๐ฐ Average purchase price was $263.83 per share.
๐ Total direct ownership now stands at 1,082.581 shares.
๐ข Benjamin M. Clark is EVP of Global Supply Chain.
โ Insider buying signals management confidence in stock value.
๐ EVP Benjamin M. Clark purchased 1,000 shares of Ecolab common stock on June 11, 2026.
๐ฐ The weighted average purchase price for the transaction was $263.831 per share.
๐ Clark's total direct ownership increased to 1,082.581 shares following the open-market buy.
๐ข Benjamin M. Clark serves as Executive Vice President of Global Supply Chain at Ecolab Inc.
๐ The transaction was filed via Form 4 with the SEC under Section 16(a) regulations.
๐ Multiple trades were executed within a price range of $263.800 to $263.840.
โ Insider buying often signals management confidence in the company's stock value.
Bullish Signals
EVP Benjamin M. Clark bought 1,000 shares.
Average purchase price was $263.831 per share.
C-suite insider purchases signal bullish future performance.
Clark's ownership aligns with public shareholder interests.
Bullish Signals
EVP Benjamin M. Clark, a senior executive responsible for global supply chain operations, has increased his direct shareholding by purchasing 1,000 shares.
The insider purchase was executed at an average price of $263.831, suggesting the executive views the current market price as attractive or fair.
Open-market purchases by C-suite executives are generally interpreted as a bullish signal regarding the company's future performance and stock valuation.
The filing confirms Clark's continued direct ownership stake in Ecolab, aligning his interests with those of public shareholders.
Morningstar analysts recommend maintaining a buy rating on Ecolab (ECL), characterizing the stock as undervalued and currently trading 15% below their $300 fair value estimate. While recent market concerns regarding Middle East conflicts have driven up raw material costs and energy prices, potentially threatening profit margins, analysts view these macroeconomic fears as market noise rather than a fundamental signal of decline. The firm expects Ecolab to effectively pass through inflationary costs with minimal long-term impact on profitability, supported by its wide economic moat derived from unmatched scale and a dominant market share in the cleaning, sanitation, and water management sectors.
The investment thesis relies heavily on Ecolab's "razor-and-blade" business model, where roughly 80% of revenue stems from high-switching-cost consumables sold to an installed base of clients, creating excess returns that have historically remained above the company's cost of capital even during downturns. Analysts project operating margins will expand from approximately 16.5% in 2024 to around 20% by 2027, driven by pricing power and new product development. This projection also factors in a planned $4.75 billion cash acquisition of CoolIT Systems, a data center cooling company, which is expected to accelerate growth within the water management segment, specifically benefiting from emerging high-tech end markets like semiconductors and AI-driven data centers.
Despite these positives, the article outlines specific risks that could influence Ecolab's valuation, including potential regulatory bans on chemical cleaning products, fluctuating raw material costs, and slowing sales growth as the company approaches saturation in major institutional accounts like restaurants and hotels. Analysts also note that increasing demand for industrial water management systems could attract new competition, potentially dampening long-term growth rates. However, the core argument remains that Ecolab's focus on delivering operational savings to customers on labor, energy, and water makes it an attractive partner even during economic slowdowns, justifying its inclusion as a top pick for investors looking past short-term market volatility.
๐ Market noise from geopolitical conflicts and inflation should not overshadow Ecolab's solid long-term fundamentals.
๐ Strong economic moat exists via a dominant razor-and-blade model covering 9.5% of the global market.
โก Margins will expand to 20% while AI and data center growth drive future revenue expansion.
๐ Morningstar targets a $300 fair value, implying Ecolab is currently undervalued by 15%.
โ ๏ธ Key risks include regulatory scrutiny, competition in water management, and potential raw material cost impacts.
๐ Ecolab (ECL) stock has declined amid concerns over Middle East conflict and inflation-driven raw material costs, which analysts view as market noise rather than signal.
๐ The company possesses a wide economic moat driven by unmatched scale in the cleaning and sanitation industry, holding roughly 9.5% of the global $165 billion market.
๐ช Approximately 80% of revenue comes from a high switching-cost "razor-and-blade" model where customers must buy Ecolab's consumables to use its equipment.
๐ฐ Morningstar estimates Ecolab is undervalued at current prices, trading 15% below their $300 fair value target based on projected excess returns over the next 20 years.
๐ค Ecolab serves as a critical strategic partner to major clients in hospitality, foodservice, and manufacturing sectors due to its fragmented yet expansive industry presence.
โ๏ธ Operating margins are expected to expand from roughly 16.5% in 2024 to around 20% by 2027 as the company successfully passes on cost inflation.
๐ The planned $4.75 billion acquisition of CoolIT Systems will bolster growth in data center cooling, a key driver for future revenue expansion.
๐ง Rising freshwater costs are anticipated to increase demand for Ecolab's industrial water management systems, which help customers save energy and water expenses.
๐ค Growth exposure to artificial intelligence is increasing through high-tech end markets like semiconductor manufacturing and data center infrastructure.
โ ๏ธ Key risks include regulatory scrutiny over chemical cleaning products, potential bans on certain formulations, and the reputational damage from any customer product recalls.
๐๏ธ Ecolab's business model offers customers savings on labor, energy, and water, making its solutions attractive even during broader economic downturns.
๐ Future sales growth may face headwinds as Ecolab already supplies many of the largest global restaurant and hotel chains.
โ๏ธ Fluctuating raw material costs could negatively impact short-term profitability, similar to other chemical manufacturing companies in the sector.
๐ฅ Increased demand for water management systems could attract new competitors, potentially slowing Ecolab's growth rate in that specific vertical.
๐ Dave Sekera, Morningstar Chief US Market Strategist, highlighted Ecolab as a top pick on The Morning Filter podcast earlier this year.
๐ต Management projects total revenue to grow at a mid-single-digit annual average rate over the coming decade.
๐ก๏ธ Customer switching costs are considered the primary source of the company's competitive advantage and ability to generate excess returns on invested capital.
๐ Expansion into new end markets alongside existing market share gains is expected to drive continued organic growth for the global leader.
๐ The fair value analysis includes planned acquisitions and assumes operating margin expansion aligned with management's long-term goals.
๐ Global high-tech sectors including semiconductors are projected to see faster growth rates compared to traditional hospitality segments.
๐ Ecolab assures customers of regulatory compliance to prevent disastrous outcomes like bacteria outbreaks that could lead to multiple customer losses.
โ๏ธ The cost of capital used in the valuation is approximately 7.5%, factoring in the company's strong competitive positioning and future growth prospects.
Bullish Signals
Trading 15% below $300 fair value target.
Generates over double revenue vs largest rival.
Controls roughly 9.5% of $165B market.
80% revenue from consumables creates high switching costs.
Strong history of excess returns above cost of capital.
Management target aligns with execution potential.
Risk Factors
Market fears inflation and energy costs will pinch Ecolab profits.
Limited large client base restricts new customer acquisition potential.
Increased competition may slow water management system growth.
Reputation risks exist from customer product recalls or bacteria outbreaks.
Chemical products face heavy regulation and potential future bans.
Bullish Signals
Ecolab is currently trading 15% below the analyst's $300 fair value estimate, presenting an attractive buying opportunity.
The company benefits from a dominant global scale, generating over double the revenue of its largest rival and controlling roughly 9.5% of the $165 billion market.
Ecolab utilizes a razor-and-blade business model where roughly 80% of revenue comes from consumables to installed base equipment, creating high switching costs and excess returns.
Analysts project Ecolab's operating margin will expand to roughly 20% by 2027, driven by pricing power and new product development.
The planned acquisition of CoolIT Systems for $4.75 billion in cash adds a data center cooling growth vector to the portfolio.
Rising freshwater costs are expected to drive demand for industrial water management systems, which will save customers money and increase Ecolab's profits.
Ecolab is securing significant long-term growth from the water business within high-tech end markets like semiconductors and data centers, including growing exposure to AI.
The company has a strong track record of returning excess returns above its cost of capital even during economic downturns and inflationary periods.
Management's long-term goal of expanding margins to 20% by 2027 is seen as being in line with execution potential.
Risk Factors
Ecolab's shares have pulled back following the conflict in the Middle East, with market concerns that profits will be pinched by inflation in raw material costs stemming from higher energy prices.
As with many chemical companies, Ecolab faces fluctuating raw material costs that could weigh on profitability.
Sales growth could become more difficult as Ecolab already sells to many of the largest restaurant and hotel chains, limiting new customer acquisition potential.
Growth in demand for water management systems will attract competition, which could result in slower growth for Ecolab in this segment.
Ecolab's reputation is vulnerable if a major customer experiences a disastrous outcome such as a product recall or bacteria outbreak linked to Ecolab products.
The company's largest environmental, social, and governance risk involves its cleaning products, which contain chemicals subject to heavy regulation and potential future bans.
If freshwater costs stop rising, demand growth for water management systems from Ecolab's industrial customers would likely slow.
UBS upgraded Ecolab (ECL) from Neutral to Buy, setting a $325 price target. The upgrade is driven by the company's exposure to high-growth sectors, specifically datacenters and semiconductor manufacturing. UBS expects these segments to lift annual volume growth from a historical 1%-2% range to approximately 4%, with their share of total sales potentially reaching 12%-14% over time.
The analyst firm anticipates that Ecolab will offset rising raw material costs through pricing power and surcharges in the near term. As inflation eases, margins are expected to expand significantly, allowing EBIT margins to exceed company targets. The upgrade also factors in strategic acquisitions like Ovivo and CoolIT, which enhance Ecolab's capabilities in ultra-pure water systems for semiconductors and cooling infrastructure for AI datacenters.
๐ UBS upgrades Ecolab to Buy, lifting price target to $325.
๐ญ Volume growth accelerates to 4% driven by datacenter and semiconductor demand.
โ๏ธ Ovivo and CoolIT acquisitions expand ultra-pure water and AI cooling capabilities.
๐ UBS upgraded Ecolab (ECL) from Neutral to Buy, driving a 3.3% stock gain on Wednesday.
๐ฐ Analysts set a $325 price target for the water treatment and industrial services company.
๐ญ Growth is expected to accelerate in datacenter and semiconductor manufacturing segments.
๐ UBS forecasts annual volume growth rising from 1%-2% historically to roughly 4%.
๐ High-growth market exposure could increase sales share to 12%-14% over time.
๐ธ EBIT margins are expected to expand as inflation eases and pricing actions take effect.
๐ The company plans to offset higher raw material costs through near-term pricing and surcharges.
๐ค Acquisition of Ovivo expands Ecolab's presence in ultra-pure water systems for semiconductors.
โ๏ธ Purchase of CoolIT strengthens its position in cooling infrastructure for AI datacenters.
๐ These strategic moves position Ecolab to benefit from increasing demand for high-tech liquid cooling.
Bullish Signals
UBS upgrades ECL to Buy citing strong institutional confidence.
Faster growth tied to datacenters and semiconductors drives upgrade.
Annual volume growth expected to rise from 1-2% to 4%.
High-growth segments could reach 12-14% sales share over time.
Acquisitions expand presence in ultra-pure water and AI cooling.
Margin expansion anticipated as pricing offsets higher raw material costs.
EBIT margins forecasted to exceed targets as inflation eases.
Risk Factors
UBS upgraded ECL to Buy with $325 target.
Prior valuation viewed as undervalued or cautious.
Growth outside datacenters/semiconductors may be insufficient.
Bullish Signals
UBS upgraded Ecolab (ECL) to Buy from Neutral, signaling strong institutional confidence in the company's growth prospects.
The upgrade is driven by faster growth tied to datacenters and semiconductor manufacturing, which are high-growth markets for the business.
UBS expects annual volume growth to rise from a historical 1%-2% to roughly 4% due to increased exposure to these strategic segments.
These high-growth segments could increase their share of sales to 12%-14% over time, driving significant future revenue expansion.
Acquisitions like Ovivo and CoolIT are strategically expanding Ecolab's presence in ultra-pure water systems for semiconductors and cooling for AI datacenters.
The company is well-positioned to benefit from increasing demand for high-tech liquid cooling infrastructure as the industry evolves.
UBS anticipates margin expansion as Ecolab offsets higher raw material costs through pricing and surcharges in the near term.
EBIT margins are forecasted to exceed company targets as inflation eases and pricing actions take full effect.
Risk Factors
UBS upgraded Ecolab (ECL) from Neutral to Buy, setting a $325 price target, which implies the stock was previously undervalued or viewed with caution by analysts.
The upgrade is driven by exposure to high-growth sectors like datacenters and semiconductors, suggesting that current growth outside these areas may be insufficient to sustain historical performance without this new tailwind.
Ecolab CEO Christophe Beck is positioning the company as a key player in the artificial intelligence and data center sector, emphasizing its ability to provide water-neutral and carbon-neutral solutions for these high-demand facilities. The article details Ecolab's strategic acquisitions of CoolIT for approximately $5 billion and Ovivo's electronics unit for $1.8 billion over the past year, which have significantly expanded its footprint in high-tech applications like liquid cooling and ultra-pure water technology for semiconductor microchips. Beck highlights that these moves place Ecolab in a position to serve an industry where major tech giants are projected to spend $600 billion this year alone.
To support this growth, Ecolab is investing $500 million into a multi-year expansion of its Allan L. Schuman Campus in Eagan, Minnesota, which will add 82,000 square feet of space for research and development across the company's 40 industries. The Minnesota Department of Employment and Economic Development has awarded a $10 million grant toward this project, which aims to upgrade chemistry labs and retain the existing workforce of nearly 800 employees while enhancing campus facilities. Beck also addresses broader economic challenges facing Minnesota, including the need for business expansion to maintain community stability and the critical importance of immigration policy for talent acquisition in an era where international students and engineers are hesitant to return to their home countries due to visa complications.
๐ Ecolab invests $500M to expand its Minnesota campus by 82,000 sq ft.
๐ฐ Major acquisitions doubled Ecolab's AI and data center industry presence.
๐ค CEO Beck prioritizes local investment despite low current Minnesota sales share.
๐ Ecolab CEO Christophe Beck is investing $500 million into a multi-year expansion of its Allan L. Schuman Campus in Eagan, adding 82,000 square feet of space.
๐ง The company aims to make future data centers "water neutral" and "carbon neutral," comparing their potential water usage to that of a car wash after recycling.
๐ค In March, Ecolab acquired CoolIT for roughly $5 billion to provide liquid cooling for data centers, significantly expanding its high-tech footprint.
๐ฐ Last year, Ecolab spent another $1.8 billion to buy the electronics unit of Ovivo, which uses ultra-pure water technology for semiconductor microchip production.
๐ง These acquisitions more than doubled Ecolab's presence in the AI and data center industry, where major tech firms are poised to spend $600 billion this year alone.
๐ญ Beck argues that Minnesota is missing out on a massive opportunity as many companies build data centers out of state despite local construction capabilities.
๐ Only 2% of Ecolab's sales occur in Minnesota, yet the CEO insists on investing locally to set an example for other businesses to follow.
๐ค Ecolab has contributed to downtown St. Paul revitalization efforts, including a $30 million investment fund and helping acquire the St. Paul Hotel.
๐ Beck highlights that international talent acquisition is becoming difficult due to federal immigration policies, which he says harms Minnesota's economy.
๐ He notes that international students are hesitant to return home for visits due to fears they cannot re-enter the U.S., complicating talent retention.
๐๏ธ The Minnesota Chamber of Commerce agrees with Beck that the state has relied too heavily on global migration to strengthen its workforce, calling the current system broken.
๐ Beck compares the evolution of data center technology to space shuttle projects, emphasizing that innovation is new by definition and must be embraced.
๐ฑ Despite concerns about environmental impacts like draining water tables, Beck prioritizes economic growth and infrastructure investment over saving the planet alone.
๐ข The Eagan expansion will upgrade chemistry labs and customer service areas while retaining an existing workforce of just under 800 employees.
๐ Beck acknowledges that the Eagan site does not check all boxes for facility location due to factors like the state's tax structure but maintains it is the right thing to do.
Bullish Signals
Ecolab invests $500M in Eagan R&D expansion.
Acquired CoolIT for $5B and Ovivo unit for $1.8B.
Footprint doubled in high-tech/AI sectors with $600B tech spending.
Secured $10M grant from Minnesota Dept of Employment.
Led community revitalization with $30M downtown investment fund.
Partnered to acquire St. Paul Hotel overlooking Rice Park.
Risk Factors
CEO admits Eagan site lacks ideal tax structure.
Only 2% of sales occur in Minnesota despite investment.
Visa issues deter international talent from returning home.
Bullish Signals
Ecolab is investing $500 million into a multi-year expansion of its Eagan facility, adding 82,000 square feet of space for research and development.
The company recently acquired CoolIT for roughly $5 billion to provide liquid cooling for data centers and bought Ovivo's electronics unit for $1.8 billion to utilize ultra-pure water technology in semiconductor production.
These strategic acquisitions more than doubled Ecolab's footprint in the high-tech and AI sectors, positioning it to participate in an industry where major tech giants are poised to spend $600 billion this year alone.
Ecolab secured a $10 million grant from the Minnesota Department of Employment and Economic Development to support its expanded Eagan facility.
The company is leading community revitalization efforts, including contributing to a downtown investment fund that received $30 million in contributions from the Bush Foundation and Securian.
Ecolab joined partners to help acquire the St. Paul Hotel overlooking Rice Park, demonstrating continued commitment to local economic development.
Risk Factors
Ecolab's CEO Christophe Beck explicitly acknowledges that the Eagan site 'doesn't check all the boxes' for locating state-of-the-art facilities, likely due to the state's tax structure.
Only 2% of Ecolab's sales take place in Minnesota, highlighting a significant disconnect between its local investment efforts and its actual revenue base in the region.
The article notes that international students and engineers are hesitant to return to their home countries due to visa complications, creating a talent acquisition risk for Ecolab's global operations.
Analysts have recently expressed bullish sentiment toward Ecolab (ECL) and Hudbay Minerals (HBM), with a focus on Ecolab. On April 29, Argus Research analyst Jim Kelleher maintained a Buy rating on Ecolab, noting its shares closed at $259.51 the previous Friday. The Street consensus for Ecolab is currently a Strong Buy, supported by an average price target of $317.44, which suggests approximately 20.9% upside from current levels. Deutsche Bank recently upgraded Ecolab to Buy with a higher price target of $325.
In addition to Kelleher's view, analysts are generally positive on Hudbay Minerals as well. Canaccord Genuity analyst Dalton Baretto maintained a Buy rating on HBM in todayโs report with a price target set at C$40.00, while shares closed last Friday at $22.80. The consensus rating for Hudbay is a Strong Buy with an average price target of $29.85, implying 24.5% upside from current levels. CIBC maintains a Buy rating with a price target of C$46.00.
Although the article begins by highlighting bullish analyst ratings on both tickers, it concludes with a summary list that includes mixed actions for Ecolab. These include price target reductions by Citi (from $330 to $325) and BofA (from $345 to $335), as well as mentions of a new Bioprocessing Applications Lab opening in Dongtan, Korea. There are also references to earnings call highlights regarding growth and margin momentum. The article ends by noting additional headlines on the stock market's mysteries, Barlow's Research Roundup, and analyst upgrades and downgrades from other sectors.
Analysts remain bullish on Ecolab and Hudbay with strong Buy ratings across major firms.
Ecolab offers 20.9% upside to a $317.44 average price target amid operational expansion.
Hudbay Minerals shows 24.5% upside potential to an average price target of C$29.85.
- ๐ผ Argus Research analyst Jim Kelleher maintains a Buy rating on Ecolab with shares closing at $259.51 last Friday.
- ๐ The general street consensus for Ecolab is Strong Buy, featuring an average price target of $317.44 indicating 20.9% upside.
- ๐ฆ Deutsche Bank upgraded Ecolab to a Buy rating with a $325.00 price target in a report dated April 20.
- ๐ฐ Canaccord Genuity analyst Dalton Baretto maintains a Buy rating on Hudbay Minerals with a C$40.00 price target.
- ๐ Hudbay Minerals shares closed at $22.80 last Friday, while the analyst consensus projects a C$29.85 average price target (24.5% upside).
- โญ Baretto is recognized as a 5-star analyst with an average return of 22.0% and covers the Basic Materials sector.
- ๐ญ Canaccord Genuity's CIBC maintained a Buy rating on Hudbay Minerals with a C$46.00 price target in a report from April 21.
- ๐ Several analysts recently adjusted their Ecolab price targets, including downgrades from Citi and Baird following earnings growth highlights.
- ๐งช Ecolab recently opened a new Bioprocessing Applications Lab in Dongtan, Korea, signaling operational expansion.
- โ ๏ธ Note that this content includes third-party press releases and the source has not reviewed or endorsed the material.
Bullish Signals
Analysts maintain a Strong Buy consensus on Ecolab (ECL).
Ecolab shows 20.9% upside to average target of $317.44.
Deutsche Bank upgraded Ecolab to Buy with $325.00 target.
Jim Kelleher holds a Buy rating with 70.0% success rate.
Hudbay Minerals (HBM) maintains a Strong Buy consensus.
Risk Factors
Analyst price targets for Ecolab (ECL) were recently lowered.
Reduced valuations signal deteriorating near-term expectations for Ecolab.
High upside relies on growth assumptions that may fail.
Execution risks could invalidate optimistic Ecolab forecasts.
Bullish Signals
Analysts maintain a Strong Buy consensus on Ecolab (ECL), indicating strong confidence in the company's future performance.
The average price target for Ecolab is $317.44, representing a significant 20.9% upside from current share levels.
Deutsche Bank upgraded Ecolab to Buy with a price target of $325.00 on April 20, highlighting institutional optimism.
Analyst Jim Kelleher holds a Buy rating with an impressive track record, showing a 70.0% success rate and average return of 34.4%.
Hudbay Minerals (HBM) maintains a Strong Buy consensus with an average price target of C$29.85, implying a 24.5% upside from current levels.
CIBC maintained a Buy rating on Hudbay Minerals with a C$46.00 price target, further validating the positive outlook for the stock.
Risk Factors
Analyst price targets for Ecolab (ECL) have been lowered multiple times recently, with Citi reducing its target from $330 to $325 and Baird cutting its target from $296 to $290, signaling deteriorating near-term valuation expectations.
BofA lowered its price target on Ecolab from $345 to $335, indicating that even some of the firm's earlier optimism is being tempered by market realities.
While analysts maintain buy ratings, the consensus price target for Ecolab ($317.44) suggests a potential upside of 20.9% from current levels of approximately $259.51, which relies on significant growth assumptions that may not materialize if execution falters.
The Reserve Bank of India (RBI) has finalized new guidelines implementing the Expected Credit Loss (ECL) provisioning framework for commercial banks, with full implementation scheduled for April 1, 2027. This marks a significant shift from the traditional "incurred loss" model to a forward-looking approach where loans are classified into three stages based on credit risk rather than just overdue status: Stage 1 for low risk, Stage 2 for significant increases in credit risk, and Stage 3 for impaired assets. The new framework aligns Indian regulations more closely with Indian Accounting Standards (Ind AS), requiring banks to use parameters like probability of default, loss given default, and exposure at default to estimate credit losses.
Under the new norms, specific prudential floor levels have been prescribed that vary by asset class and stage. For Stage 1 assets, unsecured retail loans will see a provision increase from 0.4% to 1%, while commercial real estate under construction rises to 1.25%. A key change is that loans overdue between 31 and 90 days are now classified as Stage 2, attracting a sharp provisioning requirement of 5% for most loan categories, up from approximately 0.4% under the current system. To cushion the transition, the RBI has allowed banks to amortize incremental provisioning requirements over four years (FY28 to FY31), permitting these adjustments to be phased into Common Equity Tier-1 capital.
The impact of this transition is expected to vary significantly across banking institutions. Analysts from ICRA and Nomura project that Public Sector Banks (PSBs) and mid-sized lenders will bear the greatest burden due to thinner capital buffers and higher overdue portfolios, with net worth reductions estimated between 3% and 9%. In contrast, large private sector banks appear better positioned with stronger provision buffers estimated at 2โ4% of net worth. Specific disclosures indicate wide-ranging impacts, with Bank of India potentially facing up to an 11% hit on net worth, while Kotak Mahindra Bank estimates an impact above 4.5% and IndusInd Bank projects 7โ8%. While the overall credit costs are expected to rise, improved asset quality in recent years is anticipated to moderate the total impact compared to historical scenarios.
๐ RBI shifts to forward-looking ECL models effective April 1, 2027.
๐ฐ PSBs face 3โ9% net worth hits vs. 2โ4% for private banks.
๐ก๏ธ Banks can amortize incremental provisions over FY28โFY31 into capital.
๐ Core capital ratios may dip initially but improve via new risk weights.
โ๏ธ Regulations align with global standards and NBFC provisioning approaches.
The Reserve Bank of India has issued final guidelines on Expected Credit Loss (ECL) provisioning, shifting banks from an "incurred loss" model to a forward-looking risk-based framework effective April 1, 2027.
Under the new regime, loans are classified into three stages based on credit risk rather than just overdue days: Stage 1 (low risk), Stage 2 (significant increase in credit risk), and Stage 3 (credit impaired).
The RBI has set prudential provisioning floors where Stage 2 (31โ90 days past due) now requires a 5% provision, a significant jump from the previous ~0.4% norm for most asset classes.
To ease the transition impact on capital, banks are allowed to amortize the incremental provisioning requirement over a four-year period from FY28 to FY31 into Common Equity Tier-1 (CET-1) capital.
Analysts estimate that Public Sector Banks (PSBs) could see net worth reductions ranging from 3% to 9% due to one-time provisioning hits, whereas large private sector banks are expected to have a smaller impact of 2โ4%.
Nomura and other analysts warn that PSBs and mid-sized lenders will likely bear the brunt, while large private banks with robust balance sheets are better positioned to absorb the shock.
ICRA estimates that core capital ratios could fall by less than 150 basis points initially, but institutions with thin buffers, high overdue portfolios, or significant sanctioned but undisbursed exposures face greater pressure.
IndusInd Bank estimated an ECL impact of around 2% of net worth previously, while IndusIndโs guidance suggests a transitional impact of 1.5โ1.7% of loans (7โ8% of net worth) that may moderate under the final guidelines.
Bank of India indicated a potentially higher impact of up to ~11% on its net worth compared to peers like Bank of Baroda, which estimated around 4โ4.5% of net worth.
Union Bank of India and Punjab National Bank provided specific estimates of ~3.3โ3.4% and ~6โ7% of net worth respectively for the transition impact.
Large private lenders like Kotak Mahindra Bank and IndusInd Bank are expected to be well-placed, with Kotak having absorbed an estimated ECL impact of around 2% of net worth as of Q3FY26.
The inclusion of loans overdue by 31โ90 days in Stage 2 aligns Indian banking regulations more closely with the approach already followed by non-banking financial companies (NBFCs).
A differentiated Stage 2 provisioning floor for home loans has been introduced to offer relief to banks with significant housing loan exposure.
ICICI Securities noted that some banks, such as Indian Bank, prefer to absorb the impact upfront rather than spreading it over the transition period.
Despite higher upfront provisions in segments like unsecured retail and MSME, ICRA believes improved asset quality will moderate the overall impact compared to a weaker credit cycle.
The new risk-weight framework under the guidelines could be capital-positive for the sector overall, potentially boosting CET-1 ratios of large banks by 60โ120 basis points.
Regulatory forbearance taken by banks opting for amortization may not be viewed favorably by investors and could complicate future capital-raising efforts.
The shift aligns Indian banking regulations more closely with Ind AS, enabling earlier recognition of stress and allowing proactive portfolio management.
Unsecured retail loans will attract a 1% provision under the new norms, up from 0.4%, while commercial real estate exposures under construction will require 1.25%.
Stage 3 provisioning will increase further broadly aligned with the current time-in-default framework for loans overdue by 90+ days.
Bullish Signals
Large banks show strong 2โ4% provision buffers vs PSBs.
RBI allows amortizing new provisions over four years (FY28โ31).
Better asset quality reduces ECL norm impacts.
New risk framework boosts large bank CET-1 by 60โ120 bps.
Home loan relief supports banks with high housing exposure.
Risk Factors
Provisioning hit could cut public sector bank net worth by 3โ9%.
Higher ECL norms increase costs for unsecured retail and corporate loans.
Stage 2 provisioning jumps sharply to 5% from 0.4% for overdue assets.
Core capital ratios could drop by 150 basis points at transition.
Bullish Signals
Large private sector banks appear better positioned to navigate the transition due to stronger provision buffers, estimated at 2โ4% of net worth compared to PSBs' 3โ9%.
The RBI has allowed banks to amortize incremental provisioning requirements over a four-year period from FY28 to FY31, cushioning the immediate capital impact.
Improved asset quality in recent years is likely to moderate the overall impact of the ECL norms compared to what would have been seen in a weaker credit cycle.
The revised risk-weight framework could be capital-positive for the sector overall, potentially boosting CET-1 ratios of large banks by 60โ120 basis points.
The differentiated Stage 2 provisioning floor specifically for home loans offers relief to banks with significant housing loan exposure.
Analysts note that Kotak Mahindra Bank estimated an ECL impact of around 2% of net worth, while IndusInd Bank guided for a transitional impact that may now moderate under the final guidelines.
Union Bank of India indicated an expected impact of ~3.3โ3.4% of net worth, which is on the lower end compared to peers like Punjab National Bank (~6โ7%) or Bank of India (up to ~11%).
Some banks, such as Indian Bank, have indicated a preference to absorb the impact upfront, signaling confidence in their balance sheet strength and capital management.
Risk Factors
Several public sector banks warn that the one-time provisioning hit could reduce their net worth by 3โ9%, whereas large private sector banks have stronger buffers estimated at only 2โ4%.
The new ECL norms will require significantly higher upfront provisions, particularly for unsecured retail, MSME, and corporate loan segments, exacerbating costs in these high-risk categories.
Provisioning requirements for Stage 2 loans (31โ90 days past due) will jump sharply to 5% from about 0.4% under existing norms, forcing banks to recognize losses much earlier than previously.
ICRA estimates that the transition could reduce banks' core capital ratios by up to 150 basis points at the outset, with some specific lenders like Bank of India facing an impact as high as ~11% of net worth.
Banks opting for regulatory forbearance may be viewed unfavourably by investors, potentially complicating their ability to raise future capital needed to absorb the provisioning shock.
Nomura highlights that public sector banks and mid-sized lenders will bear the brunt of the transition due to thinner capital buffers and higher overdue portfolios compared to large private banks.
The inclusion of loans overdue by 31โ90 days in Stage 2 means banks must provision against assets that are not yet 90 days past due, leading to immediate pressure on provisioning adequacy.
BMO Capital has reaffirmed its Buy rating on Ecolab stock (ECL) in a recent report released today, maintaining a price target of $345.00. John McNulty from BMO Capital covers the Basic Materials sector and focuses on companies such as LyondellBasell, Dow Inc, and RPM International. According to TipRanks data, McNulty has achieved an average return of 4.2% with a 50.61% success rate on his stock recommendations. This positive analyst sentiment is contrasted by another recent development where Baird lowered its price target for Ecolab from $296 to $290, while Barclays maintained its Buy rating with a price target of $300.00.
Financial performance based on the quarter ending December 31 shows significant growth, with the company reporting quarterly revenue of $4.2 billion and net profit of $563.9 million. This represents an increase from last year's revenue of $4.01 billion and net profit of $472.9 million. Ecolab reported Q1 adjusted EPS of $1.70, which met the consensus estimate of $1.70, while management sees Q2 adjusted EPS ranging between $2.02 and $2.12 against a consensus expectation of $2.10.
Despite the positive analyst ratings and strong earnings report, corporate insider activity presents a contrasting signal with negative sentiment toward the stock. Analysis of recent activity from 117 insiders indicates an increase in share sales over the past quarter compared to earlier this year. Notably, in February 2026, Cook Gregory B, the Executive Vice President & President โ Industrial Group of Ecolab, sold 3,519 shares for a total value of $1,070,655.75. The article notes that TipRanks has not reviewed the content and may receive compensation for its placement on the site.
๐ BMO Capital maintains a Buy rating with a $345 price target.
๐ฐ Q4 revenue rose to $4.2B and net profit reached $563.9M.
โ ๏ธ Insider selling increased as 117 executives sold shares recently.
๐ Baird lowered its price target slightly but remains positive.
๐ฏ The company provided adjusted EPS guidance for Q2 earnings.
๐ BMO Capital reiterated a Buy rating on Ecolab (ECL) with a price target of $345.00.
๐ผ Analyst John McNulty covers the Basic Materials sector and has historically achieved a 50.61% success rate.
๐ฐ Q4 earnings showed revenue growth to $4.2 billion compared to $4.01 billion in the prior year.
๐ Net profit increased significantly to $563.9 million from $472.9 million last year.
โ ๏ธ Corporate insider sentiment remains negative due to a recent uptick in share selling among 117 insiders.
๐ธ EVP & President Gregory B Cook sold 3,519 shares in February for approximately $1.07 million.
๐ Baird lowered its price target for the stock from $296 to $290 despite maintaining a positive stance.
๐๏ธ Ecolab released its Q4 earnings report covering the period ending December 31.
๐ฏ The company provided guidance of $2.02-$2.12 adjusted EPS for Q2 against a consensus of $2.10.
๐ฌ Recent earnings highlights indicated continued momentum in growth and margins for the company.
๐ข LyondellBasell, Dow Inc, and RPM International are other stocks covered by analyst John McNulty.
Bullish Signals
BMO Capital reaffirmed its Buy rating on Ecolab (ECL) with an impressive price target of $345.00.
Barcayls also maintained a Buy rating, indicating continued analyst confidence in the stock's prospects.
Ecolab reported strong quarterly revenue growth to $4.2 billion compared to $4.01 billion in the prior year.
The company delivered robust net profit of $563.9 million, significantly beating last year's $472.9 million.
Q1 adjusted EPS of $1.70 met consensus estimates exactly, demonstrating accurate forecasting and operational discipline.
For Q2, management raised guidance for adjusted EPS between $2.02 and $2.12, exceeding the consensus estimate of $2.10.
Risk Factors
Corporate insider sentiment is negative due to increased selling activity by executives over the past quarter.
EVP & PRES โ INST GROUP, Gregory B. Cook, sold 3,519 shares recently for a total of $1,070,655.75 in February 2026.
Analyst Baird lowered Ecolab's price target from $296 to $290.
Ecolab Life Sciences announced the opening of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, marking its first bioprocessing facility in Asia. This strategic expansion aims to enhance global bioprocessing capabilities and support biopharmaceutical manufacturers operating in one of the world's most advanced manufacturing markets. The new center will conduct a full range of process development activities, from early-stage testing through scale-up studies that replicate manufacturing conditions, leveraging Ecolabโs existing network in the United States and the United Kingdom.
The facility is designed to facilitate hands-on collaboration between customers and Ecolabโs bioprocessing experts to optimize purification processes and enhance cost efficiency. By establishing a local presence in Korea, Ecolab addresses the increasing pressure on Asian manufacturers to scale quickly while meeting rigorous regulatory standards. Localized expertise allows clients to progress development more efficiently by avoiding overseas material transfers, ensuring consistency across global operations. The company specifically highlighted its affinity resin technologies as part of this long-term investment to help customers drive growth and scale advanced therapies with reliability.
Jenny Tan, vice president and general manager of Ecolab Life Sciences for APAC and India, emphasized that the new center strengthens the ability to work side-by-side with customers by combining deep local expertise with a global, integrated bioprocessing network. Ecolab described the facility as part of its broader commitment to innovation and sustainability, aligning with goals to protect 2 billion people from infections and conserve drinking water for 1 billion people by 2030. The company serves over 170 countries with $16 billion in annual sales, employing 48,000 associates across 40 industries, including life sciences, food safety, healthcare, and data centers.
๐ฐ๐ท Ecolab opens first Asian bioprocessing lab in Dongtan, Korea.
๐ค Local facility enables hands-on process optimization and cost efficiency.
๐ Company aims to protect 2 billion people from infections by 2030.
๐ฐ Ecolab generates $16B annual sales across 170+ countries.
๐งฌ Offers end-to-end solutions for safely developing life-saving drugs.
๐ฐ๐ท Ecolab Life Sciences officially opened a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, marking its first bioprocessing facility in Asia.
๐ค The new center will enable hands-on collaboration between customers and local experts to optimize purification processes and enhance cost efficiency.
๐ BPAL Korea supports the full range of process development activities from early-stage testing through scaled manufacturing replication studies.
๐ Located in a global hub for biosimilars, the facility allows manufacturers to avoid overseas material transfers while maintaining regulatory standards.
๐ผ Jenny Tan, VP and GM of Ecolab Life Sciences APAC and India, noted that local expertise combined with a global network helps customers scale faster.
๐ฌ The expansion reinforces Ecolab's existing bioprocessing applications network in the United States and the United Kingdom.
๐ฐ Ecolab delivers $16 billion in annual sales and employs 48,000 associates across more than 170 countries.
๐ The company aims to protect 2 billion people from infections by 2030 while conserving drinking water for 1 billion people globally.
๐งฌ Ecolab offers end-to-end solutions in life sciences to support the development and manufacturing of life-saving drugs safely and consistently.
๐ง Beyond life sciences, Ecolab serves as a major provider of ultra-pure water for chip manufacturing and AI data centers.
Bullish Signals
Opens first Asian BPAL in Dongtan, Korea.
Strengthens global US and UK development networks.
Enables efficient local testing without overseas transfers.
Invests in affinity resin tech for scale-up.
Serves 170 countries with $16 billion annual sales.
Aims to protect 2 billion from infections by 2030.
Risk Factors
Article ignores financial risks, declining metrics, or competitive threats.
Capital expenditure for Dongtan center may hurt short-term earnings.
Bullish Signals
Ecolab Life Sciences is expanding its global bioprocessing capabilities with the opening of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, marking its first bioprocessing facility in Asia.
The new Korea BPAL supports a full range of process development activities from early-stage testing through scale-up studies, strengthening Ecolab's established network in the United States and United Kingdom.
Having local bioprocessing experts in Korea enables customers to progress development more efficiently by avoiding overseas material transfers while maintaining cost efficiencies.
Ecolab Life Sciences continues its long-term investment in innovation across its bioprocessing portfolio, including affinity resin technologies, to help customers drive growth and scale advanced therapies with speed and reliability.
With annual sales of $16 billion serving over 170 countries and 40 industries, Ecolab remains a trusted partner for millions of customers, advancing solutions supported by AI technology and data-driven insights.
Ecolab has set an ambitious goal by 2030 to help protect 2 billion people from infections and conserve drinking water for 1 billion people while enhancing business performance.
Risk Factors
The article focuses entirely on expansion and positive achievements with no mention of financial risks, declining metrics, or competitive threats.
Despite the positive tone, investors should note that significant capital expenditure is required for this new Advanced Development and Applications Center in Dongtan, Korea, which could impact short-term earnings before the facility generates returns.
Ecolab Inc (NYSE:ECL) reported strong first-quarter 2026 results, with adjusted diluted earnings per share (EPS) growing by 13% and organic sales rising by 4%. The revenue growth was driven primarily by a 3% increase from value pricing and a 1% gain from volume. Operating income margins expanded by 70 basis points to 16.8%, while organic operating income margins also reached 16.8% after expanding by the same amount. Performance was particularly robust in specific sectors, with global high-tech and digital segments growing over 20%, life sciences accelerating to 11% growth (with bioprocessing sales more than doubling), and specialty sales climbing 9% due to cost-optimizing innovations. Other strong performers included food and beverage at 5% growth, pest elimination at 7%, and an overall alignment with the company's strategy to stabilize high-margin growth initiatives.
Looking ahead, the company expects adjusted diluted EPS growth of between 12% and 15% for 2026, though this excludes short-term headwinds from the recent CoolIT acquisition. Management anticipates that the CoolIT deal will reduce quarterly EPS by approximately $0.20 in the second half of 2026, but the amortization of the prior Nalco acquisition is expected to roll off, neutralizing this impact by 2027. Ecolab continues to face challenges, including high single-digit commodity cost inflation projected to persist through the year, a specific 9% increase in Q2, and ongoing pressure from supply chain costs exacerbated by geopolitical tensions such as the conflict in the Middle East. Additionally, the paper and heavy water segments remain under pressure but are showing signs of stabilization.
Despite these macroeconomic headwinds, CEO Christophe Beck emphasized that the company's guidance is based 90% on execution rather than external demand conditions, assuming a cautious customer posture driven by rising energy costs. The company aims to stabilize gross margins in the second half of the year and achieve its strategic target of a 20% operating income margin by 2027. Growth engines in high-tech, life sciences, and digital sectors are viewed as less sensitive to energy price fluctuations, with Ovivo contributing significantly to microelectronics and CoolIT addressing data center cooling needs. The One Ecolab initiative is also performing well, particularly within the food and beverage vertical among top customers, helping to offset broader market pressures and drive sustainable revenue expansion.
๐ Adjusted EPS rose 13% QoQ driven by volume, pricing, and high-tech AI demand.
Operating income margin expanded 70 basis points to reach 16.8%.
Global High-tech and Digital sectors grew over 20% on AI adoption.
Life Sciences growth hit 11% with bioprocessing sales more than doubling.
Pest Elimination and Specialty segments recorded robust growth of 7% and 9%.
Ecolab targets achieving its 20% operating income margin goal by 2027.
CEO Beck is confident in stabilizing gross margins despite inflation challenges.
Ovivo and CoolIT offerings projected for significant mid-teens and 30% growth.
Management expects 2026 EPS growth between 12% and 15% excluding acquisitions.
Risk Factors
9% commodity cost increase expected in Q2 amid single-digit inflation.
CoolIT acquisition cuts H2 2026 EPS by $0.20 due to dilution.
Paper and heavy water segments remain unstable and under pressure.
Middle East conflict raises global energy costs and supply chain risk.
Bullish Signals
Ecolab Inc (NYSE:ECL) reported a strong first quarter with adjusted diluted EPS growth of 13%, driven by a 4% increase in organic sales.
The company achieved an operating income margin expansion of 70 basis points to 16.8%, demonstrating effective cost management and pricing power.
Global High-tech and Digital sectors delivered more than 20% growth, fueled by digital adoption and AI infrastructure expansion.
Life Sciences growth accelerated to 11%, with bioprocessing sales more than doubling, highlighting successful investments in innovation.
Pest Elimination and Specialty segments showed robust growth of 7% and 9% respectively, supported by strategic initiatives like One Ecolab.
Ecolab is on track to achieve its 20% operating income margin target by 2027, with expectations of further expansion in the second half of the year.
CEO Christophe Beck expressed confidence in stabilizing gross margins in the second half and managing energy costs effectively despite inflation challenges.
High-tech offerings including Ovivo (projected mid-teens growth) and CoolIT (exceeding 30% growth) are expected to contribute significantly to portfolio enhancement.
Management expects EPS growth for 2026 of 12% to 15% excluding short-term acquisition impacts, indicating sustained long-term value creation.
Risk Factors
The company faces high single-digit commodity cost inflation, with Q2 expected to see a 9% increase in costs, which is projected to persist throughout the year and negatively impact second-quarter EPS growth.
The pending CoolIT acquisition is anticipated to reduce quarterly EPS by approximately $0.20 in the second half of 2026, introducing near-term dilution pressures.
Challenges in the paper and heavy water segments have caused these divisions to come under pressure, and they are currently only beginning to stabilize.
The conflict in the Middle East has led to increased global energy costs, adding further supply chain pressure across the company's operations.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)